Results 31 to 40 of about 5,139,025 (256)

A Novel Method for Estimating the Dosage of Cold Atmospheric Plasmas in Plasma Medical Applications

open access: yesApplied Sciences, 2021
Cold atmospheric plasmas (CAPs) used in plasma medicine have shown great potential in various aspects including wound healing, dermatology, cancer therapy, etc.
Jing Li   +10 more
doaj   +1 more source

Multimodal Comparison of Cold Atmospheric Plasma Sources for Disinfection

open access: yesApplied Sciences
While atmospheric pressure plasma sources are emerging as potentially innovative instruments in medicine, some aspects of the interaction between plasma and biological substrates remain unclear.
Leonardo Zampieri   +9 more
doaj   +1 more source

Time Behaviour of Helium Atmospheric Pressure Plasma Jet Electrical and Optical Parameters

open access: yesApplied Sciences, 2017
Low temperature plasma jets gained increased interest in the last years as a potential device in many life science applications, including here human or veterinary medicine.
Ioana Cristina Gerber   +6 more
doaj   +1 more source

Cold Atmospheric Pressure Plasma in Wound Healing and Cancer Treatment

open access: yesApplied Sciences, 2020
Plasma medicine is gaining increasing attention and is moving from basic research into clinical practice. While areas of application are diverse, much research has been conducted assessing the use of cold atmospheric pressure plasma (CAP) in wound ...
Lars Boeckmann   +12 more
doaj   +1 more source

Realtime RONS monitoring of cold plasma-activated aqueous media based on time-resolved phosphorescence spectroscopy

open access: yesScientific Reports
Besides many efforts on the detection and quantification of reactive oxygen and nitrogen species (RONSs) in the aqueous media activated by the cold atmospheric plasma, to get a better insight into the dominant mechanism and reactive species in medical ...
Donya Taheri   +5 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Redox for Repair: Cold Physical Plasmas and Nrf2 Signaling Promoting Wound Healing

open access: yesAntioxidants, 2018
Chronic wounds and ulcers are major public health threats. Being a substantial burden for patients and health care systems alike, better understanding of wound pathophysiology and new avenues in the therapy of chronic wounds are urgently needed.
Anke Schmidt, Sander Bekeschus
doaj   +1 more source

Atmospheric Pressure Plasma Irradiation Facilitates Transdermal Permeability of Aniline Blue on Porcine Skin and the Cellular Permeability of Keratinocytes with the Production of Nitric Oxide

open access: yesApplied Sciences, 2021
The transdermal delivery system of nutrients, cosmetics, and drugs is particularly attractive for painless, noninvasive delivery and sustainable release.
Sunmi Lee   +4 more
doaj   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy